ClinVar Genomic variation as it relates to human health
Help
- Interpretation:
-
Pathogenic/Likely pathogenic
- Review status:
- criteria provided, multiple submitters, no conflicts
- Submissions:
- 8
- First in ClinVar:
- May 21, 2016
- Most recent Submission:
- Feb 7, 2023
- Last evaluated:
- Oct 13, 2022
- Accession:
- VCV000226119.10
- Variation ID:
- 226119
- Description:
- single nucleotide variant
Help
NM_000444.6(PHEX):c.1735G>A (p.Gly579Arg)
- Allele ID
- 227925
- Variant type
- single nucleotide variant
- Variant length
- 1 bp
- Cytogenetic location
- Xp22.11
- Genomic location
- X: 22219070 (GRCh38) GRCh38 UCSC
- X: 22237187 (GRCh37) GRCh37 UCSC
- HGVS
-
Nucleotide Protein Molecular
consequenceNM_000444.6:c.1735G>A MANE Select NP_000435.3:p.Gly579Arg missense NM_001282754.2:c.1735G>A NP_001269683.1:p.Gly579Arg missense NC_000023.11:g.22219070G>A NC_000023.10:g.22237187G>A NG_007563.2:g.191267G>A P78562:p.Gly579Arg - Protein change
- G579R
- Other names
- NM_000444.5(PHEX):c.1735G>A(p.Gly579Arg)
- NM_001282754.1(PHEX):c.1735G>A(p.Gly579Arg)
- Canonical SPDI
- NC_000023.11:22219069:G:A
- Functional consequence
- -
- Global minor allele frequency (GMAF)
- -
- Allele frequency
- -
- Links
- ClinGen: CA10576256
- UniProtKB: P78562#VAR_006745
- dbSNP: rs875989883
- VarSome
Help
Aggregate interpretations per condition
Interpreted condition | Interpretation | Number of submissions | Review status | Last evaluated | Variation/condition record |
---|---|---|---|---|---|
Pathogenic/Likely pathogenic | 5 | criteria provided, multiple submitters, no conflicts | Jan 3, 2022 | RCV000211521.5 | |
Pathogenic | 2 | criteria provided, multiple submitters, no conflicts | Oct 13, 2022 | RCV000396672.6 | |
Likely pathogenic | 1 | no assertion criteria provided | Apr 1, 2017 | RCV000578203.1 |
Submitted interpretations and evidence
HelpInterpretation (Last evaluated) |
Review status (Assertion criteria) |
Condition (Inheritance) |
Submitter | More information | |
---|---|---|---|---|---|
Likely pathogenic
(Apr 05, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Affected status: yes
Allele origin:
germline
|
Center of Genomic medicine, Geneva, University Hospital of Geneva
Accession: SCV000268522.1
First in ClinVar: May 21, 2016 Last updated: May 21, 2016 |
Comment:
The identified PHEX mutation is the likely genetic cause for the hypophosphatemic rickets observed in the patient.
Age: 20-29 years
Sex: female
|
|
Pathogenic
(Oct 28, 2013)
|
criteria provided, single submitter
Method: clinical testing
|
(X-linked inheritance)
Affected status: yes
Allele origin:
germline,
de novo
|
Institute of Human Genetics, Klinikum rechts der Isar
Accession: SCV000599652.1
First in ClinVar: May 21, 2016 Last updated: May 21, 2016 |
Observation 1:
Zygosity: 1 Hemizygote
Sex: male
Tissue: blood
Observation 2:
Zygosity: 1 Single Heterozygote
Sex: female
Tissue: blood
Observation 3:
Zygosity: 1 Hemizygote
Sex: male
Tissue: blood
Observation 4:
Zygosity: 1 Hemizygote
Sex: male
Tissue: blood
Observation 5:
Zygosity: 1 Single Heterozygote
Sex: female
Tissue: blood
Observation 6:
Zygosity: 1 Single Heterozygote
Sex: female
Tissue: blood
|
|
Pathogenic
(May 31, 2018)
|
criteria provided, single submitter
Method: curation
|
Affected status: unknown
Allele origin:
unknown
|
SIB Swiss Institute of Bioinformatics
Accession: SCV000803531.1
First in ClinVar: May 03, 2018 Last updated: May 03, 2018 |
Comment:
This variant is interpreted as a Pathogenic, for Hypophosphatemic rickets, X-linked dominant, in X-linked Dominant manner. The following ACMG Tag(s) were applied: PP3 => Multiple … (more)
This variant is interpreted as a Pathogenic, for Hypophosphatemic rickets, X-linked dominant, in X-linked Dominant manner. The following ACMG Tag(s) were applied: PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PS4-Moderate => Recurrent mutation found in unrelated patients. (PMID:9199930). PS3 => Well-established functional studies show a deleterious effect (PMID:11468271,12727977). PM6 => Assumed de novo, but without confirmation of paternity and maternity (PMID:24684036). (less)
|
|
Pathogenic
(Sep 19, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000329463.5
First in ClinVar: Dec 06, 2016 Last updated: Mar 08, 2017 |
Comment:
The G579R missense variant in the PHEX gene has been reported previously as de novo and in association with X-linked hypophosphatemic rickets (Rowe et al., … (more)
The G579R missense variant in the PHEX gene has been reported previously as de novo and in association with X-linked hypophosphatemic rickets (Rowe et al., 1997; Durmaz et al., 2013; Radlovic et al., 2014). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). G579R is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. In addition, another nucelotide change at the same codon (c.1735 G>C) also leading to the G579R missense change, a missense variant in at the same residue (G579V), and missense variants in nearby residues (H580P, F582S, H584P) have all been reported in the Human Gene Mutation Database in association with PHEX-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Furthermore, functional studies of the G579R variant have shown that it results in incomplete glycosylation of the protein leading to failed expression at the plasma membrane and degradation within the endoplasmic reticulum (Sabbagh et al., 2001; Sabbagh et al., 2003). (less)
|
|
Pathogenic
(Jan 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002058796.1
First in ClinVar: Jan 15, 2022 Last updated: Jan 15, 2022 |
Comment:
Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000226119,VCV000438542, PS1_S). The variant … (more)
Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000226119,VCV000438542, PS1_S). The variant is located in a well-established functional domain or exonic hotspot, where pathogenic variants have frequently reported (PM1_M).Different missense changes at the same codon (p.Gly579Val, p.Gly579Glu) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000372777,VCV000378359, PMID:9097956, PM5_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.931, 3CNET: 0.997, PP3_P). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Short stature (present) , Skeletal dysplasia (present)
Zygosity: 1 Single Heterozygote
|
|
Pathogenic
(Nov 17, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002812640.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(Oct 13, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Affected status: unknown
Allele origin:
germline
|
Invitae
Accession: SCV001217754.4
First in ClinVar: Apr 15, 2020 Last updated: Feb 07, 2023 |
Comment:
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 579 of the PHEX protein (p.Gly579Arg). … (more)
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 579 of the PHEX protein (p.Gly579Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hypophosphatemic rickets (PMID: 9097956, 9199930, 18625346, 29858904). ClinVar contains an entry for this variant (Variation ID: 226119). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PHEX protein function. Experimental studies have shown that this missense change affects PHEX function (PMID: 11468271). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Likely pathogenic
(Apr 01, 2017)
|
no assertion criteria provided
Method: research
|
Affected status: yes
Allele origin:
germline
|
Department of Traditional Chinese Medicine, Fujian Provincial Hospital
Accession: SCV000680000.1
First in ClinVar: Feb 03, 2018 Last updated: Feb 03, 2018 |
Clinical Features:
Hypomineralization of enamel (present) , Osteomalacia (present) , Elevated alkaline phosphatase (present) , Bowing of the legs (present) , Femoral bowing (present) , Hypophosphatemia (present) … (more)
Hypomineralization of enamel (present) , Osteomalacia (present) , Elevated alkaline phosphatase (present) , Bowing of the legs (present) , Femoral bowing (present) , Hypophosphatemia (present) , Short stature (present) (less)
|
Functional evidence
HelpThere is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Genetic analysis of three families with X-linked dominant hypophosphatemic rickets. | Lin X | Journal of pediatric endocrinology & metabolism : JPEM | 2018 | PMID: 29858904 |
X-linked hypophosphatemic rickets: case report. | Radlović V | Srpski arhiv za celokupno lekarstvo | 2014 | PMID: 24684036 |
Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. | Ichikawa S | Bone | 2008 | PMID: 18625346 |
Structure and function of disease-causing missense mutations in the PHEX gene. | Sabbagh Y | The Journal of clinical endocrinology and metabolism | 2003 | PMID: 12727977 |
Disease-causing missense mutations in the PHEX gene interfere with membrane targeting of the recombinant protein. | Sabbagh Y | Human molecular genetics | 2001 | PMID: 11468271 |
Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. | Francis F | Genome research | 1997 | PMID: 9199930 |
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). | Rowe PS | Human molecular genetics | 1997 | PMID: 9097956 |
PMID:9097956 | - | - | - | - |
PMID:9199930 | - | - | - | - |
Text-mined citations for rs875989883...
HelpThese citations are identified by LitVar using
the rs number, so they may include citations for more than one variant
at this location. Please review the LitVar results carefully for your
variant of interest.
Record last updated Mar 18, 2023